Stress, thyroid function, and the brain’s GABA system form a tightly connected feedback loop. Because each system affects the others, disruptions can create a cycle of stress sensitivity, cognitive fog, and emotional imbalance. Understanding this interconnected network allows clinicians and patients to approach symptoms more holistically—focusing on stress regulation, thyroid support, and nervous system balance to restore harmony across the entire neuroendocrine system.
Featured
Peer-Reviewed Publication: Integrative Framework for Thyroid & Endocrine Resilience
Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category leadership.
Anti-depressant Non-Response: Why They Sometimes Fall Short
For many individuals with depression, antidepressant medications lead to meaningful improvement. For others, symptoms persist despite appropriate dosing and duration. This pattern is often referred to as “antidepressant non-response. New research has started to suggest that methylation should become a greater focus in an adjunctive nutritional approach in individuals who do not respond optimally to antidepressant monotherapy. There is also growing evidence that inflammatory and metabolic factors may help identify those most likely to benefit from this adjunctive approach.* [1]
Read now
The HPA–Thyroid–GABA Connection
Read now
Estrogen: No Black Box Warning—Now What?
For more than two decades, fear stemming from early, oversimplified interpretations of the Women’s Health Initiative led many women and clinicians to avoid hormone replacement therapy, culminating in a black box warning on estrogen. In 2025, the FDA removed that warning for estrogen-only therapies, reflecting clearer evidence that risks depend heavily on age, timing, hormone type, and route of administration—not the universal danger once assumed. Updated research shows that starting hormone therapy within ten years of menopause, using bioidentical formulations, and choosing non-oral routes can significantly reduce risks, while estrogen-only therapy has not been shown to raise breast cancer risk. The label change does not mean hormone therapy is risk-free, but it does open the door to individualized, evidence-based decision-making. With better data and more nuance, women and clinicians can move forward with informed conversations rather than fear-driven avoidance.
Read now
Detox Pathways and MTHFR
Learn how MTHFR mutations impact detoxification and why supporting methylation with L-methylfolate and key nutrients is critical for hormone balance, toxin clearance, and cellular health.
Read now
Social Wellness vs. Self-Care: Why Social Connection Matters for Mental Health
Learn about what exactly social wellness is, and why its so crucial to maintaining your mental health.
Read now
When Is the Best Time to Take B Vitamins?
Learn how to optimize the impact of your B-complex supplements.
Read now
